East Initial India Pharmaceuticals Private Limited

East Initial India Pharmaceuticals Private Limited - chemicals in Lucknow, Uttar Pradesh, India. Directors, charges & compliance details.
CIN U24290UP2022PTC166646 Incorporated 28 June 2022 ROC Uttar Pradesh HQ Lucknow, Uttar Pradesh, India
Active Private Limited Company chemicals MSME · Micro
Revenue · FY 2024
₹6.29 Lakh
Latest filing
Net loss · FY 2024
₹66,631
Net margin -10.6%
EBITDA · FY 2024
-₹53,364
EBITDA margin -8.5%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About East Initial India Pharmaceuticals Private Limited

Data last updated:

East Initial India Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 28 June 2022.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2022PTC166646.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Deepak Singh and Rubi Singh.

Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lucknow, Uttar Pradesh.

As per the financials filed for FY 2024, the company reported a revenue of ₹6.29 Lakh. For the same year it recorded a net loss of ₹66,631 (net margin -10.6%) and EBITDA of -₹53,364 (EBITDA margin -8.5%).

East Initial India Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-12-0006836). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24290UP2022PTC166646
Registration Number 166646
Incorporation Date 28 June 2022
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-12-0006836

Recognitions & Rankings of East Initial India Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-UP-12-0006836

Contact details

East Initial India Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh.

  • Registered Address
    83 84 Himcity Part 1, Ganeshpur Rahmanpur Chinhat, Lucknow, Uttar Pradesh, India – 226001
  • Industry
    Chemicals, Other Chemical Product, Manufacturing
Comprehensive company report
East Initial India Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of East Initial India Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles45Wholesale and retail trade and repair of motor vehicles and motorcycles

To see the full business activity and turnover split of East Initial India Pharmaceuticals Private Limited, buy the company report.

Financials of East Initial India Pharmaceuticals Private Limited

FY 2025 filings available

East Initial India Pharmaceuticals Private Limited reported revenue of ₹6.29 Lakh for FY 2024.

Revenue · FY 2024
₹6.29 Lakh
Net loss · FY 2024
₹66,631 margin -10.6%
EBITDA · FY 2024
-₹53,364 margin -8.5%

Financial Statement Summary

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹53,364
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹66,631
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin-8.5%
Net Profit Margin-10.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of East Initial India Pharmaceuticals Private Limited, buy the company report.

Board of directors of East Initial India Pharmaceuticals Private Limited

East Initial India Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Deepak SinghDirector28 Jun 20224 Years 4 MonthsCurrent
Rubi SinghDirector28 Jun 20224 Years 4 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for East Initial India Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for East Initial India Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

East Initial India Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Deepak Singh was appointed as Director on 28 Jun 2022.

AGM
East Initial India Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
East Initial India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Appointed
Deepak Singh was appointed as Director.
Appointed
Rubi Singh was appointed as Director.
Incorporation
28 Jun 2022
East Initial India Pharmaceuticals Private Limited was registered on 28 Jun 2022 with Roc Uttar Pradesh I & aged 4 years 4 months as per MCA records.

Frequently asked questions

East Initial India Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 28 June 2022 (4+ years old) and is registered under CIN U24290UP2022PTC166646.

East Initial India Pharmaceuticals has 2 current directors:

The latest financial statements of East Initial India Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of East Initial India Pharmaceuticals is U24290UP2022PTC166646. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

East Initial India Pharmaceuticals was incorporated on 28 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

Deepak Singh was appointed as Director on 28 Jun 2022. Rubi Singh was appointed as Director on 28 Jun 2022.

Yes, East Initial India Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-12-0006836).

The registered office of East Initial India Pharmaceuticals is at 83 84 Himcity Part 1, Ganeshpur Rahmanpur Chinhat, Lucknow, Uttar Pradesh, India – 226001.

East Initial India Pharmaceuticals operates in the chemicals industry, in the other chemical product segment.

The compliance status of East Initial India Pharmaceuticals is compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.